Veradermics, Incorporated (MANE)

NYSE: MANE · Real-Time Price · USD

102.82

-2.50 (-2.37%)

Aug 21, 2026, 4:00 PM EDT - Market closed

Veradermics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	4,296	-	-	-
Market Cap Growth	-	-	-	-
Enterprise Value	3,476	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.00	0	-	0.06
Net Debt / Equity Ratio	-1.01	-0.99	-1.04	-1.13
Net Debt / FCF Ratio	10.46	1.98	2.24	1.15
Quick Ratio	70.25	15.64	11.54	5.34
Current Ratio	70.53	16.66	11.77	5.75
Return on Equity (ROE)	-	-72.06%	-82.08%	-
Return on Assets (ROA)	-	-43.45%	-45.79%	-
Return on Capital Employed (ROCE)	-12.60%	-50.40%	-52.70%	-119.40%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-2096.15%	-1.09%	-	-

SEC Filings: 10-K · 10-Q